β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
about
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.Glial Modulation by N-acylethanolamides in Brain Injury and NeurodegenerationPalmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndromeRole of transient receptor potential ankyrin 1 channels in Alzheimer's diseaseAlzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.PPAR agonists as therapeutics for CNS trauma and neurological diseasesTransient receptor potential vanilloid 1-immunoreactive signals in murine enteric glial cells.Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.The anti-inflammatory compound palmitoylethanolamide inhibits prostaglandin and hydroxyeicosatetraenoic acid production by a macrophage cell lineMetabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.Clinical studies and anti-inflammatory mechanisms of treatments.The Effect of Sea Buckthorn ( L.) Seed Oil on UV-Induced Changes in Lipid Metabolism of Human Skin Cells
P2860
Q21093231-D519C4BD-C1AB-439D-8F07-E830F7860240Q24630453-07AFA739-569B-43AD-A28D-7F3AF73A5D0BQ26747533-567BF287-BCEA-4269-9119-329D07DD689AQ26775847-933CCD94-8197-4E47-BA8E-5B610598C847Q27303152-F7C1B7D9-1DFD-4AA5-BE3E-D250F3A40EE9Q33959032-DAF31600-9599-4068-B5C7-A689BFAD7AC4Q37400355-E5013B8E-A8B6-4F88-95EC-2B410555C1E4Q37444247-3D2C0A63-1CE1-406E-BD07-A1B89FF81E0FQ38196398-33B399A1-8871-4FE8-8E80-A62580AA652CQ38563981-58D60438-729C-410B-9FFC-2CEFA75211A8Q38709659-EAE40631-CCA7-4A76-8455-C0207B4707B0Q38777732-B990FC14-6107-4A1F-97AA-E32FC4FE218EQ41953638-340B6238-86C7-4CEB-8857-BE0DCB43CFC1Q42605212-33F1D8C1-9B60-47E5-AA88-926EA93FA795Q47124754-C27AC503-47A4-481F-85B0-A76D6C604F0BQ58710605-E3CF57E5-B65D-47DD-87F5-23206B00872F
P2860
β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
β-Amyloid exacerbates inflamma ...... but not CB₁ or CB₂ receptors.
@en
β-Amyloid exacerbates inflamma ...... but not CB₁ or CB₂ receptors.
@nl
type
label
β-Amyloid exacerbates inflamma ...... but not CB₁ or CB₂ receptors.
@en
β-Amyloid exacerbates inflamma ...... but not CB₁ or CB₂ receptors.
@nl
prefLabel
β-Amyloid exacerbates inflamma ...... but not CB₁ or CB₂ receptors.
@en
β-Amyloid exacerbates inflamma ...... but not CB₁ or CB₂ receptors.
@nl
P2093
P2860
P1476
β-Amyloid exacerbates inflamma ...... but not CB₁ or CB₂ receptors.
@en
P2093
Ana Isabel Castillo
Carmen Vázquez
Cristina Benito
Francisco Javier Fernández-Sánchez
Julián Romero
Lourdes Ruiz-Valdepeñas
Rosa María Tolón
P2860
P304
P356
10.1111/J.1476-5381.2012.01889.X
P407
P577
2012-06-01T00:00:00Z